AIS
PFE icon

Advocate Investing Services’s Pfizer PFE Stock Holding History

Advocate Investing Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
15,148
+3
+0% +$78 0.28% 73
2026
Q1 		$425K Buy
15,145
+178
+1% +$4.74K 0.36% 66
2025
Q4 		$373K Buy
+14,967
New +$377K 0.33% 63

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Advocate Investing Services's PFE Position: Q2 2026 in Review

Advocate Investing Services increased its Pfizer (PFE) stake by 0.02% in Q2 2026, buying an estimated $78 and bringing the position to 15,148 shares worth $365K. The position accounts for 0.28% of the portfolio, ranked #73.

Advocate Investing Services first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $425K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Advocate Investing Services held 15,148 shares of Pfizer worth $365K as of Q2 2026.
  • Advocate Investing Services bought 3 Pfizer shares in Q2 2026, an estimated $78.
  • Pfizer made up 0.28% of Advocate Investing Services's portfolio in Q2 2026, its #73 holding.
  • Advocate Investing Services first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Advocate Investing Services's Pfizer position peaked at $425K in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Advocate Investing Services's 13F filing for Q2 2026, filed 29 Jul 2026.